Related references
Note: Only part of the references are listed.Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Andrew B. West
EXPERIMENTAL NEUROLOGY (2017)
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells
Kenneth Thirstrup et al.
SCIENTIFIC REPORTS (2017)
Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
Genta Ito et al.
BIOCHEMICAL JOURNAL (2016)
Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers
Kyle B. Fraser et al.
NEUROLOGY (2016)
LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts
Tomoki Kuwahara et al.
SCIENTIFIC REPORTS (2016)
LRRK2 autophosphorylation enhances its GTPase activity
Zhiyong Liu et al.
FASEB JOURNAL (2016)
Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury
Ravindra Boddu et al.
HUMAN MOLECULAR GENETICS (2015)
Macrophage Liver Kinase B1 Interacts with IKKβ and Inhibits Inflammatory Signaling in Response to LPS
Zhaoyu Liu et al.
FASEB JOURNAL (2015)
Ten Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors to the Clinic
Andrew B. West
MOVEMENT DISORDERS (2015)
Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy
Jason Schapansky et al.
HUMAN MOLECULAR GENETICS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
Alexandria Beilina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
Ruth Chia et al.
NATURE COMMUNICATIONS (2014)
Disease Penetrance of Late-Onset Parkinsonism A Meta-analysis
Joanne Trinh et al.
JAMA NEUROLOGY (2014)
Intermediates in the Guanine Nucleotide Exchange Reaction of Rab8 Protein Catalyzed by Guanine Nucleotide Exchange Factors Rabin8 and GRAB
Zhong Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson's Disease Risk
David A. MacLeod et al.
NEURON (2013)
Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
Daniah Trabzuni et al.
PLOS ONE (2013)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Martin C. Herzig et al.
HUMAN MOLECULAR GENETICS (2011)
Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
Philip J. Webber et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Role of Rab GTPases in Membrane Traffic and Cell Physiology
Alex H. Hutagalung et al.
PHYSIOLOGICAL REVIEWS (2011)
Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
Zdenek Berger et al.
BIOCHEMISTRY (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
Elisa Greggio et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
Javier Alegre-Abarrategui et al.
HUMAN MOLECULAR GENETICS (2009)
Structural Mechanisms for Regulation of Membrane Traffic by Rab GTPases
Meng-Tse Gabe Lee et al.
TRAFFIC (2009)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Rab10, a target of the AS160 rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane
Hiroyuki Sano et al.
CELL METABOLISM (2007)
Rabs 8A and 14 are targets of the insulin-regulated Rab-GAP AS160 regulating GLUT4 traffic in muscle cells
Shuhei Ishikura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Phosphate-binding tag, a new tool to visualize phosphorylated proteins
E Kinoshita et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking
M Larance et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural clues to Rab GTPase functional diversity
SR Pfeffer
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)